recent articles
Visiopharm are pleased to announce the novel launch of an automated, and IVDR certified, AI-driven digital pathology workflow for University Medical Center Utrecht (UMCU) in the Netherlands. The workflow will be based on existing and new next...
Assessment of relevant quantitative data from tumors by histology is a cornerstone of cancer research and diagnostics. Today it is a challenge to understand, define and quantify tumor heterogeneity in a way that has practical utility for...
FLAGSTAFF, Ariz. — September 7, 2011 — Flagship Biosciences, a leading provider of FFPE and frozen tissue analysis for pharmaceutical and medical device development, announced today the launch of new heterogeneity testing...
© 2023 Tissuepathology.com. All rights reserved. Millennial Consulting. | Web Design by Zealth Digital Marketing